GlassScriptPhysician profile
Tarek Ali Dbouk
NPI 1215114913
$7,117.69
in general payments reported to CMS, 2019-2025
34 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 85% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $817 · 2021: $765 · 2022: $827 · 2023: $938 · 2024: $2,058 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $1,356 · Travel and Lodging: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $1,355.80 |
| Travel and Lodging | $1,285.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,989.29 | 2021-2025 | Altis, Saffron |
| Intuitive Surgical, INC. | $1,500.00 | 2024 | |
| Medtronic, INC. | $689.76 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $477.68 | 2019-2020 | |
| Abbvie INC. | $467.59 | 2019-2022 | |
| Astellas Pharma US INC | $316.38 | 2019-2023 | Myrbetriq, Veozah |
| Meditrina | $221.42 | 2022-2025 | |
| Allergan, INC. | $193.83 | 2019-2021 | |
| Axonics, INC. | $174.18 | 2020-2023 | Axonics, Bulkamid |
| Gynesonics, INC. | $156.48 | 2021-2022 | |
| Therapeuticsmd, INC. | $130.96 | 2019-2021 | |
| Acessa Health INC. | $113.53 | 2021 | |
| Myovant Sciences INC. | $88.16 | 2021-2022 | |
| Organon LLC | $80.86 | 2022 | |
| Pfizer INC. | $68.67 | 2022-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $53.28 | 2019-2022 | |
| Medtronic USA, INC. | $45.75 | 2019-2020 | |
| Minerva Surgical, INC | $37.00 | 2022-2023 | |
| Roche Diagnostics Corporation | $35.16 | 2019 | |
| Mylan Pharmaceuticals INC. | $30.65 | 2021 | |
| Lupin INC. | $29.76 | 2020-2021 | |
| Coopersurgical, INC. | $26.35 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $25.80 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.19 | 2023 | Exparel |
| Sage Therapeutics, LLC | $18.03 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.29 | 2019 | |
| Cook Medical LLC | $15.45 | 2019 | |
| Gilead Sciences, INC. | $14.99 | 2019 | |
| Scynexis, INC. | $14.80 | 2022 | |
| Mayne Pharma Commercial LLC | $14.46 | 2021 | |
| Ethicon US, LLC | $14.07 | 2019 | |
| Exeltis, USA INC. | $13.38 | 2021 | |
| Duchesnay USA Incorporated | $12.70 | 2019 | |
| Electromed, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Dbouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.